ClinSpec Diagnostics Raises £2.4M Funding

ClinSpec Diagnostics, a Glasgow, Scotland-based early cancer detection company, raised £2.4m in funding led by Mercia’s EIS Funds with Scottish Investment Bank, SIS Ventures, EoS Advisory and the University of Strathclyde. The company intends to use the funds to progress its multi-cancer development program, including completion of its second brain cancer trial, and the development of a multi-cancer algorithm covering the most common cancers.

ClinSpec Diagnostics Secures £2.4M to Advance Early Cancer Detection Technology

ClinSpec Diagnostics is a Glasgow, Scotland-based early cancer detection company that has developed a way of detecting cancer at an early stage using a simple blood test. Since the company was established in 2016, they have conducted studies on brain, prostate and pancreatic cancers, which have highlighted the technology’s potential as a multi-cancer early detection test.

ClinSpec Diagnostics is a Glasgow-based early cancer detection company that has developed a way to detect cancer at an early stage using a simple blood test.

5 years ago

ClinSpec Diagnostics Secures £2.4M to Advance Early Cancer Detection Technology

ProblemHealthcare

Solution

Covered on